Madurahydroxylactone
is a secondary metabolite from Nonomuria rubra (former Actinomadura rubra) with in vitro activity against Gram-positive bacteria and belongs to the family of benzo [a] naphthacenequinones. A series of derivatives of madurahydroxylactone were synthesized to investigate the effect on the antibacterial activity. Reaction with alcohols and amines gave cyclic acetals or aminals derived from the lactone form, whereas other amino reagents like hydroxylamines and acyl or sulfonyl hydrazides led to the corresponding imine derivatives of the aldehyde. Hydrazine, alkyl and aryl hydrazines react with madurahydroxylactoneunder cyclization to give compoundsof the newheterocyclic basic structure naphthaceno [l ,2-g] phthalazine. Somenew compoundsstrongly inhibit Gram-positive bacteria, in part stronger than the parent compound.
In the seventies, in a search for pigment-forming actinomycetes, a strain of Nonomuriarubra (formerly designated Actinomadua rubra) was isolated which produces a mixture of red coloured secondary metabolites possessing indicator properties and showing activity against
Gram-positive bacteria1'^. This complex, formerly called maduramycin, consists of madurahydroxylactone and homologues thereof. Recently single crystal X-ray structure analysis established madurahydroxylactone as 3,9, 1 1 , 14, 1 5-pentahydroxy-7-methoxy-10-methyl-1,8,13-trioxol ,3,5,6,8, 1 3-hexahydronaphthaceno[l ,2-/] isobenzofurane la3?4). Thus madurahydroxylactone is the prime component of the novel group of benzofajnaphthacenequinone antibiotics, famous members of which are the antifungal benanomicins5) and pradimicins6). Madurahydroxylactone is a weak acid and in acidic or neutral mediumit forms a stable lactone, insoluble in water (la)7). In alkaline medium, however, madurahydroxylactone readily dissolves forming alkali salts of an or//zo-formylcarboxylic acid called maduranic acid (lb, 3-formyl-l,9,ll,14-tetra- hydroxy-7-methoxy-1 0-methyl-8, 1 3-dioxo-5,6,8, 1 3-tetrahydrobenzo[a]naphthacene-2-carboxylic acid). Analogous behaviour was observed for phthalaldehydic8).
As madurahydroxylactone l a exhibited an interesting but therapeutical insufficient antibacterial activity we started a derivatization programme. This report presents the syntheses and antibacterial activities of derivatives.
Chemistry
Derivatives based on the hydroxylactone moiety la ( Table 1) : The backbone of madurahydroxylactone is a benzo [a] naphthacenequinone.
The rings C and E constitute a 2,2'-dihydroxy-biphenyl moiety in which the phenyl moieties are further bridged by an ethano linker (C5-C6 in ring D). Whereas in a,a-disubstitued biphenyls without ethano bridge noncoplanarity is enforced, the X-ray structure of madurahydroxylactone shows only a moderate torsion in the C~E-biphenyl3). The situation changes in the case of substitution of the corresponding phenolic hydroxyls which are directed towards each other.
Completely acetylated derivatives of madurahydroxylactone and related compounds are not easily achieved and the esters are relatively unstable under hydrolytic conditions.
Thus, the !H NMRspectra of the pentaacetyl derivative 2, obtained by reaction of madurahydroxylactone la with acetic anhydride in pyridine, clearly showed the presence of two diastereoisomers at room temperature. This is a consequence of the fact that the pentaacetate 2 contains a stereogenic center at C3 and a chiral axis from ring C to E.
INEPT experiments (CDC13, 300K) allowed to assign the singlets at 7.37 and 7.40ppm to H-3 and the singlets at 7.41 and 7.45 ppm to H-4. Whenthe temperature was raised the frozen ethano bridge began to flip and spectra obtained at 380 K (DMSO-<i6) showed only one signal for the protons at C-3 (7.47 ppm) and C-4 (7.71 ppm), respectively. Although the protons of the ethano bridge exhibited a similar behaviour, full interpretation of the complex signals, obtained at room temperature was not possible. Wefound that madurahydroxylactone la forms a well crystalline derivative 3 upon heating with urea in acidic solution/ The urea derivative is insoluble in tetrahydrofuran and can be used for purification of crude madurahydroxylactone4).
Lower alkyl homologues of madurahydroxylactone had been claimed to be isolated from the culture mediumof a mutant of Actinomadura rubra2\ Weprepared a series of corresponding 3-O-alkyl derivatives (4a~f) by boiling madurahydroxylactone in a mixture of tetrahydrofuran and an excess of the desired alcohol. The reaction can be accelerated by addition of a catalytic amount of concentrated sulfuric acid in the presence of molecular Fig. 2. NOV. 1999 sieves to bind the reaction water. Specimens of synthetic and natural compoundsshowed identical spectroscopic and physico-chemical properties thus confirming the proposed structures. The more nucleophilic aliphatic and aromatic amines readily reacted with madurahydroxylactone to form the 3-amino derivatives 5a~c (from primary amines) and 6a, b (from secondary amines) even in the absence of any catalyst.
It was observed that prolonged treatment of madurahydroxylactone in alkali caused decomposition of the natural compound.Reaction in concentrated potassium hydroxide under controlled conditions led to two distinct products which could be unequivocally characterized as the dicarboxylic acid 9 and the maduralactone 7. Obviously, the orf/zo-formylcarboxylic acid moiety in madurahydroxylactone underwent a Cannizzaro reaction. In the presence of formaldehyde, a crossed Cannizzaro reaction occurred with concomitant introduction of a further methyl substituent at C12 in ring A leading to 12-methylmaduralactone 8. Derivatives based on the or^/zo-formylcarboxylic acid moiety of lb (Fig 3, Table 2 (6500) 295 (6800) 465 (4400) 292 (4700) 468 (2700) 302 (12300) 466 (12200) 301 (13000) 465 (11700) 293 (8000) 466 (4800) 292 (6200) 496 (3900) 283 (4100) 478 (1800) 289 ( With the exception of aminals (3-ammo maduralactones) Fig. 3 . NOV. 1999 4d, 5a, 6a and 6b the compounds were inactive against all tested Gram-negative bacteria; in Table 4 Madurahydroxylactone Pentaacetate 2 A solution of madurahydroxylactone (100 mg, 0.2 mmol) in a mixture of acetic anhydride (3 ml) and pyridine (1 ml) was stirred at 50°C for 1 hour. Then the reaction mixture was diluted with ice water (10ml) and stirred for 1 hour.
The crystals were dissolved in chloroform and chromatographed on silica gel column eluting with chloroform. The fraction containing the desired product was concentrated and precipitated with acetonitrile to give yellow crystals, HOmg (78%) (acetonitrile). 3 -Anilino-maduralactone 5a A solution of1 (250mg, 0.5mmol) and aniline (95mg, 1 mmol) in tetrahydofuran (5 ml) was refluxed for 30 minutes with stirring. The precipitated red crystals were washed with water and dried over P4O10 to give 5a (185 mg, 70%). 107.90, 111.60, 114.89, 123.45, 134.13, 135.86, 147.23, 148.56, 149.24, 161.72, 180.69, 190.74 (8-,13-C) .
To a mixture of madurahydroxylactone (purity 97%) (245 mg, 0.5mmol) and aqueous formaldehyde (36%) (2 ml, 0.02mol) in methanol (2ml) was added KOH(2 g) with stirring. The mixture was refluxed for 1 hour. After cooling to ambient temperature the solution was diluted with water (10ml) and carefully acidified under ice cooling with HG1 to pH 3. The crude product was stirred in aqueous NaHCO3 with stirring, filtered off, washed with water and dried to give red crystals of8 (192mg, 76% 113.54, 114.02, 118.25, 119.09, 122.42, 128.64, 130.15, 130.75, 139.82, 140.64, 146.88, 148.62, 150.36, 157.33, 162.07, 162.40, 164.18, 185.59, 187 .70 (9-, 14-G).
2-Methyl-maduraphthalazinl -one 1 7 A solution of madurahydroxylactone (80%, 293 mg, 0.2 mmol) and methylhydrazine (lOOmg 0.05 ml, 1 mmol) in 5 ml of acetic acid was refluxed with stirring for 8 hours. The red crystals were filtered off, washed with water, and dried in vacuo over P4Oi0 to give 17 (175mg, 70%), mp >300°C , s, 3.80, 3.78 (2X3H, s, 7.32, 7.12 (2X1H, s, 8.42 (1H, s, ll.19, 13.20, 13.55, 14.07 (4X1H, s, .
13C NMR (DMSO-d6) 29.23, 60.96 (OCH3), 106.22, 109.62, 111.19, 113.94, 118.14, 119.17, 122.31, 128.58, 129.72, 130.10, 130.65, 139.24, 146.82, 148.33, 148.57, 150.27, 156.71, 157.08, 157.29, 162.00, 162.32, 162.62, 164.13, 187.61,  14-C).
2-ft-Propyl-maduraphthalazinl -one 1 8 A solution of madurahydroxylactone (500mg, 1 mmol) and?z-propylhydrazine hydrochloride (120 mg 1 mmol) in 5 13C NMR (DMSO-d6), 20.6 (OCOCH3), 29.36, , 49.05 (NCH2), 60.9 (OCH2), 106.34, 109.74, 111.16, 113.60, 114.29, 118.29, 119.57, 122.51, 128.62, 129.65, 130.77, 139.79, 147.02, 148.83, 150.39, 156.96, 157.40, 162.40, 162.96, 170.36, 187.74, 185 .63 (9-, 14-C).
2-(2-Diethoxy)ethyl-maduraphthalazin-1 -one 20 To a solution of lOOmg(0.2mmol) of madurahydroxylactone 1 in of acetic acid (30ml) were added 2,2-diethoxyethylhydrazine (300 /il). The mixture was heated to reflux. After 30 minutes the mixture was cooled. The solvent was evaporated to ca. a third of the original volume and treated with diethylether to precipitate the product. The red crystals were filtered off maintaining the desired product 20, yield 104mg (0.16mmol, 80%). 2-^7-Propyl-1 0, 1 2, 1 5, 1 6-tetraacetoxy-maduraphthalazin-
1-one 22
A solution of 2-^-propyl-maduraphthalazin-l-one 18 (lOOmg, 0.2 mmol) in acetic anhydride (3 ml) and pyridine (lml) was warmed up to 100°C with stirring for 1 hour. 
